Characteristics of New Users of Aclidinium Bromide, Aclidinium/Formoterol, and Other COPD Medications in the United Kingdom, Denmark, and Germany.

Elena Rivero-Ferrer Morten Olesen Estel Plana Jaume Aguado Nuria Saigi-MorguiAnnalisa RubinoSami Z DaoudAlejhandra LeiSusanna Perez-Gutthann Nina Sahlertz Kristiansen Nina Sahlertz Kristiansen Jesper Hallas Cristina Rebordosa Cristina Rebordosa

Published in: Clinical drug investigation (2022)

Aclidinium and aclidinium/formoterol were mostly prescribed according to label, with preference given to older patients with more severe COPD and to patients with a high prevalence of comorbidities and comedication use.

Keyphrases

chronic obstructive pulmonary disease
lung function
physical activity
early onset
cross sectional